Leptomeningeal metastasis: a review of the pathophysiology, diagnostic methodology, and therapeutic landscape

A Nguyen, A Nguyen, OT Dada, PD Desai, JC Ricci… - Current …, 2023 - mdpi.com
The present review aimed to establish an understanding of the pathophysiology of
leptomeningeal disease as it relates to late-stage development among different cancer …

Everything old is new again: drug repurposing approach for non-small cell lung cancer targeting MAPK signaling pathway

AS Jain, A Prasad, S Pradeep, C Dharmashekar… - Frontiers in …, 2021 - frontiersin.org
Non-small cell lung cancer (NSCLC) is a prominent subtype of lung carcinoma that accounts
for the majority of cancer-related deaths globally, and it is responsible for about 80% to 85 …

[HTML][HTML] The role of selected non-coding RNAs in the biology of non-small cell lung cancer

K Kiełbowski, K Ptaszyński, J Wojcik… - Advances in Medical …, 2023 - Elsevier
Lung cancer is the second most frequently diagnosed cancer worldwide and a leading
cause of cancer-related deaths. Non-small cell lung carcinoma (NSCLC) represents 85% of …

Baicalein: A review on its anti‐cancer effects and mechanisms in lung carcinoma

N Chandrashekar, A Pandi - Journal of Food Biochemistry, 2022 - Wiley Online Library
Plant‐derived flavonoids are reported to function as potential anti‐cancer agents against
different types of cancer. Baicalein (BE) is an important flavonoid found in the roots of …

Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review

MA Mansour, AM AboulMagd, SH Abbas… - RSC …, 2023 - pubs.rsc.org
Lung cancer is the second most common cause of morbidity and mortality among cancer
types worldwide, with non-small cell lung cancer (NSCLC) representing the majority of most …

Isoliquiritigenin inhibits non-small cell lung cancer progression via m6A/IGF2BP3-dependent TWIST1 mRNA stabilization

Y Cui, Y Wu, C Wang, Z Wang, Y Li, Z Jiang, W Zhao… - Phytomedicine, 2022 - Elsevier
Abstract Background N 6-methyladenosine (m 6 A) has been identified to regulate the
tumorigenesis and development of various tumors, including non-small cell lung cancer …

Activities against lung cancer of biosynthesized silver nanoparticles: a review

JL Mejía-Méndez, ER López-Mena, E Sánchez-Arreola - Biomedicines, 2023 - mdpi.com
Nanomedicine is an interdisciplinary field where nanostructured objects are applied to treat
or diagnose disease. Nanoparticles (NPs) are a special class of materials at nanometric …

Duration of immunotherapy in non-small cell lung cancer survivors: a lifelong commitment?

C Putzu, S Canova, P Paliogiannis, R Lobrano, L Sala… - Cancers, 2023 - mdpi.com
Simple Summary Lung cancer is one of the most common human cancers and the leading
cause of cancer-related mortality worldwide. The advent of immunotherapy for the treatment …

Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response

EK Kleczko, AT Le, TK Hinz, TT Nguyen, A Navarro… - Cancer letters, 2023 - Elsevier
Lung cancers bearing oncogenically-mutated EGFR represent a significant fraction of lung
adenocarcinomas (LUADs) for which EGFR-targeting tyrosine kinase inhibitors (TKIs) …

Emerging roles of TRIM27 in cancer and other human diseases

C Yu, D Rao, T Wang, J Song, L Zhang… - Frontiers in Cell and …, 2022 - frontiersin.org
As a member of the TRIM protein family, TRIM27 is a RING-mediated E3 ubiquitin ligase that
can mark other proteins for degradation. Its ubiquitination targets include PTEN, IκBα and …